Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients

Skin Lesions in Patient With Metastatic Breast Cancer

The HER2-directed antibody-drug conjugate DHES0815A in advanced

Real World Evidence of Neoadjuvant Docetaxel/Carboplatin

Anatomic distribution of pruritus

How safe is it to administer dual anti-HER2 block with pertuzumab

Practical aspects of pertuzumab treatment in patients with breast

Phase II trial of pertuzumab and trastuzumab in patients with

Comparison of adverse effects of trastuzumab with other drug

Targeting HER2 in Breast Cancer: Latest Developments on Treatment

New therapies in HER2-positive breast cancer: A major step towards

Efficacy and Safety of Pertuzumab in Metastatic Breast Cancer

IJMS, Free Full-Text

PDF) Pruritus related to trastuzumab and pertuzumab in HER2 +

Phase I study of LZM005 in patients with HER2-positive metastatic

Pertuzumab in HER2-positive early breast cancer: current use and